Autoantibodies against the β3-Adrenoceptor Protect from Cardiac Dysfunction in a Rat Model of Pressure Overload

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wang, Jin ^a   Li, Meixia ^b   Ma, Xiurui ^c   Bai, Kehua ^a   Wang, Li ^a   Yan, Zi ^a   Lv, Tingting ^d   Zhao, Zhiqing ^a,e   Zhao, Rongrui ^a   Liu, Huirong ^a,d  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c Shanxi Cardiovascular Hospital   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR ANTIBODY; CALCIUM CHANNEL L TYPE; CALCIUM ION; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CHRONOTROPISM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC DIMENSION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC DIMENSION; HEART LEFT VENTRICLE FRACTIONAL SHORTENING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART MUSCLE CELL; HUMAN; INOTROPISM; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; RAT;

AGED; ANIMALS; AUTOANTIBODIES; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-3;

EID: 84885398354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078207     Document Type: Article

References (53)

1. Redfield MM, Jacobsen SJ, Burnett JC Jr., Mahoney DW, Bailey KR, et al. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289: 194-202. doi:10.1001/jama.289.2.194. PubMed: 12517230.
2. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, et al. (2007) Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. J Heart Lung Transplant 26: 769-781. doi:10.1016/j.healun.2007.06.004. PubMed: 17692781.
3. Lohse MJ, Engelhardt S, Eschenhagen T, (2003) What is the role of beta-adrenergic signaling in heart failure? Circ Res 93: 896-906. doi:10.1161/01.RES.0000102042.83024.CA. PubMed: 14615493.
4. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, et al. (1992) Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89: 803-815. doi:10.1172/JCI115659. PubMed: 1311717.
5. Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, et al. (2003) Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112: 1067-1079. doi:10.1172/JCI200318213. PubMed: 14523044.
6. Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, et al. (1990) Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 86: 1658-1663. doi:10.1172/JCI114888. PubMed: 1700798.
7. Holthoff HP, Zeibig S, Jahns-Boivin V, Bauer J, Lohse MJ, et al. (2012) Detection of anti-beta1-AR autoantibodies in heart failure by a cell-based competition ELISA. Circ Res 111: 675-684. doi:10.1161/CIRCRESAHA.112.272682. PubMed: 22811559.
8. Pei J, Li N, Chen J, Li X, Zhang Y, et al. (2012) The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure. Eur J Heart Fail 14: 887-894. doi:10.1093/eurjhf/hfs082. PubMed: 22713286.
9. Chiale PA, Rosenbaum MB, Elizari MV, Hjalmarson A, Magnusson Y, et al. (1995) High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol 26: 864-869. doi:10.1016/0735-1097(95)00262-2. PubMed: 7560610.
10. Elies R, Ferrari I, Wallukat G, Lebesgue D, Chiale P, et al. (1996) Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol 157: 4203-4211. PubMed: 8892658.
11. Rosenbaum MB, Chiale PA, Schejtman D, Levin M, Elizari MV, (1994) Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' heart disease. J Cardiovasc Electrophysiol 5: 367-375. doi:10.1111/j.1540-8167.1994.tb01174.x. PubMed: 8019712.
12. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J, (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89: 2760-2767. doi:10.1161/01.CIR.89.6.2760. PubMed: 8205690.
13. Krause EG, Bartel S, Beyerdörfer I, Wallukat G, (1996) Activation of cyclic AMP-dependent protein kinase in cardiomyocytes by anti-beta 1-adrenoceptor autoantibodies from patients with idiopathic dilated cardiomyopathy. Blood Press Suppl 3: 37-40. PubMed: 8973767.
14. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, et al. (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113: 1419-1429. doi:10.1172/JCI200420149. PubMed: 15146239.
15. Matsui S, Fu ML, Katsuda S, Hayase M, Yamaguchi N, et al. (1997) Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 29: 641-655. doi:10.1016/S0735-1097(96)00552-9. PubMed: 9140822.
16. Zuo L, Bao H, Tian J, Wang X, Zhang S, et al. (2011) Long-term active immunization with a synthetic peptide corresponding to the second extracellular loop of beta1-adrenoceptor induces both morphological and functional cardiomyopathic changes in rats. Int J Cardiol 149: 89-94. doi:10.1016/j.ijcard.2009.12.023. PubMed: 20096470.
17. Matsui S, Persson M, Fu HM, Hayase M, Katsuda S, et al. (2000) Protective effect of bisoprolol on beta-1 adrenoceptor peptide-induced autoimmune myocardial damage in rabbits. Herz 25: 267-270. doi:10.1007/s000590050018. PubMed: 10904850.
18. Liu HR, Zhao RR, Jiao XY, Wang YY, Fu M, (2002) Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J Am Coll Cardiol 39: 1866-1873. doi:10.1016/S0735-1097(02)01865-X. PubMed: 12039504.
19. Kaya Z, Leib C, Katus HA, (2012) Autoantibodies in heart failure and cardiac dysfunction. Circ Res 110: 145-158. doi:10.1161/CIRCRESAHA.111.243360. PubMed: 22223211.
20. Johnson M, (1998) The beta-adrenoceptor. Am J Respir Crit Care Med 158: S146-S153. doi:10.1164/ajrccm.158.supplement_2.13tac110. PubMed: 9817738.
21. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H, (1996) Functional beta3-adrenoceptor in the human heart. J Clin Invest 98: 556-562. doi:10.1172/JCI118823. PubMed: 8755668.
22. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, et al. (1990) Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 82: I12-I25. PubMed: 2164894.
23. Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, et al. (2001) Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103: 1649-1655. doi:10.1161/01.CIR.103.12.1649. PubMed: 11273992.
24. Morimoto A, Hasegawa H, Cheng HJ, Little WC, Cheng CP, (2004) Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am J Physiol Heart Circ Physiol 286: H2425-H2433. doi:10.1152/ajpheart.01045.2003. PubMed: 14962832.
25. Zhao Q, Wu TG, Jiang ZF, Chen GW, Lin Y, et al. (2007) Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure. Cardiovasc Drugs Ther 21: 85-90. doi:10.1007/s10557-007-6016-4. PubMed: 17440824.
26. Zhao Q, Zeng F, Liu JB, He Y, Li B, et al. (2013) Upregulation of beta3-adrenergic receptor expression in the atrium of rats with chronic heart failure. J Cardiovasc Pharmacol Ther 18: 133-137. doi:10.1177/1074248412460123. PubMed: 23008154.
27. Rasmussen HH, Figtree GA, Krum H, Bundgaard H, (2009) The use of beta3-adrenergic receptor agonists in the treatment of heart failure. Curr Opin Investig Drugs 10: 955-962. PubMed: 19705338.
28. Niu X, Watts VL, Cingolani OH, Sivakumaran V, Leyton-Mange JS, et al. (2012) Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol 59: 1979-1987. doi:10.1016/j.jacc.2011.12.046. PubMed: 22624839.
29. Moens AL, Leyton-Mange JS, Niu X, Yang R, Cingolani O, et al. (2009) Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol 47: 576-585. doi:10.1016/j.yjmcc.2009.06.005. PubMed: 19766235.
30. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841-842. doi:10.1161/01.CIR.93.5.841. PubMed: 8598070.
31. Zhang ZS, Cheng HJ, Onishi K, Ohte N, Wannenburg T, et al. (2005) Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther 315: 1203-1211. doi:10.1124/jpet.105.089672. PubMed: 16135702.
32. Yang X, Wang F, Chang H, Zhang S, Yang L, et al. (2008) Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation. J Hypertens 26: 1629-1635. doi:10.1097/HJH.0b013e328304dbff. PubMed: 18622242.
33. Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, et al. (1999) Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 84: 722-728. doi:10.1161/01.RES.84.6.722. PubMed: 10189360.
34. Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, et al. (2007) Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol 102: 28-41. doi:10.1007/s00395-006-0627-y. PubMed: 17006633.
35. Lorenz JN, Robbins J, (1997) Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am J Physiol 272: H1137-H1146. PubMed: 9087586.
36. Suzuki M, Ohte N, Wang ZM, Williams DL Jr., Little WC, et al. (1998) Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy. Cardiovasc Res 39: 589-599. doi:10.1016/S0008-6363(98)00166-7. PubMed: 9861301.
37. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ, (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100. doi:10.1007/BF00656997. PubMed: 6270629.
38. Ren J, Wold LE, (2001) Measurement of Cardiac Mechanical Function in Isolated Ventricular Myocytes from Rats and Mice by Computerized Video-Based Imaging. Biol Proced Online 3: 43-53. doi:10.1251/bpo22. PubMed: 12734580.
39. Sipido KR, Callewaert G, (1995) How to measure intracellular [Ca2+] in single cardiac cells with fura-2 or indo-1. Cardiovasc Res 29: 717-726. doi:10.1016/S0008-6363(96)88645-7. PubMed: 7606761.
40. Porstmann T, Kiessig ST, (1992) Enzyme immunoassay techniques. An overview. J Immunol Methods 150: 5-21. doi:10.1016/0022-1759(92)90061-W. PubMed: 1613258.
41. Xiao RP, Spurgeon HA, O'Connor F, Lakatta EG, (1994) Age-associated changes in beta-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest 94: 2051-2059. doi:10.1172/JCI117559. PubMed: 7962551.
42. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML, (1999) Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29: 43-51. doi:10.3109/08916939908995971. PubMed: 10052684.
43. Magnusson Y, Höyer S, Lengagne R, Chapot MP, Guillet JG, et al. (1989) Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol 78: 42-48. PubMed: 2478327.
44. Fu LX, Magnusson Y, Bergh CH, Liljeqvist JA, Waagstein F, et al. (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91: 1964-1968. doi:10.1172/JCI116416. PubMed: 7683693.
45. Nagatomo Y, Yoshikawa T, Kohno T, Yoshizawa A, Baba A, et al. (2009) A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 15: 224-232. doi:10.1016/j.cardfail.2008.10.027. PubMed: 19327624.
46. Delcayre C, Swynghedauw B, (1991) Biological adaptation and dysadaptation of the heart to chronic arterial hypertension: a review. J Hypertens Suppl 9: S23-S29; discussion: 1686453.
47. Grossman W, Jones D, McLaurin LP, (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56-64. doi:10.1172/JCI108079. PubMed: 124746.
48. James MA, Saadeh AM, Jones JV, (2000) Wall stress and hypertension. J Cardiovasc Risk 7: 187-190. PubMed: 11006887.
49. Kupari M, Turto H, Lommi J, (2005) Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 26: 1790-1796. doi:10.1093/eurheartj/ehi290. PubMed: 15860517.
50. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH, (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352. doi:10.7326/0003-4819-114-5-345. PubMed: 1825164.
51. Frey N, Olson EN, (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79. doi:10.1146/annurev.physiol.65.092101.142243. PubMed: 12524460.
52. Bornholz B, Weidtkamp-Peters S, Schmitmeier S, Seidel CA, Herda LR, et al. (2013) Impact of human autoantibodies on beta1-adrenergic receptor conformation, activity, and internalization. Cardiovasc Res 97: 472-480. doi:10.1093/cvr/cvs350. PubMed: 23208588.
53. Du Y, Yan L, Du H, Wang L, Ding F, et al. (2012) beta1-adrenergic receptor autoantibodies from heart failure patients enhanced TNF-alpha secretion in RAW264.7 macrophages in a largely PKA-dependent fashion. J Cell Biochem 113: 3218-3228. doi:10.1002/jcb.24198. PubMed: 22628174.